NOVO NORDISK (NVO.N) CEO said liver disease is an obvious entry point and,
despite recent setbacks, cardiovascular remains another clear strategic focus.
2026-09-21
NOVO NORDISK (NVO.N) CEO said liver disease is an obvious entry point and,
despite recent setbacks, cardiovascular remains another clear strategic focus.